Trial Profile
European phase III pivotal trial investigating the efficacy of voclosporin for the prevention of renal transplant rejection.
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 21 Nov 2011
Price :
$35
*
At a glance
- Drugs Voclosporin (Primary) ; Tacrolimus
- Indications Renal transplant rejection
- Focus Registrational; Therapeutic Use
- 10 Nov 2011 Isotechnika receives positive Scientific Advice from the EMA for this trial.
- 02 Nov 2011 New trial record
- 18 Oct 2011 Isotechnika receives positive Scientific Advice from the EMA for its proposed protocol, according to a Isotechnika Pharma media release.